Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine

J Clin Psychiatry. 2010 Jan;71(1):91-2. doi: 10.4088/JCP.09l05388.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Brain-Derived Neurotrophic Factor / blood*
  • Clozapine / therapeutic use*
  • Dopamine Agents / therapeutic use*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Humans
  • Memantine / therapeutic use*
  • Schizophrenia / blood
  • Schizophrenia / drug therapy*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Brain-Derived Neurotrophic Factor
  • Dopamine Agents
  • Clozapine
  • Memantine